本页面由Tiger Trade Technology Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

22.93
+1.105.02%
成交量:22.88万
成交额:517.38万
市值:28.43亿
市盈率:-180.71
高:22.96
开:22.03
低:21.95
收:21.83
52周最高:31.77
52周最低:11.86
股本:1.24亿
流通股本:8,824.23万
量比:0.37
换手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):-0.1269
每股收益(LYR):-0.1269
净资产收益率:-9.30%
总资产收益率:-1.95%
市净率:15.01
市盈率(LYR):-180.71

数据加载中...

2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities